November 14, 2025

How the biological clock ticks in the female reproductive tract – Breakthrough of the Year Award 2025 for Ângela Gonçalves

How the biological clock ticks in the female reproductive tract – Breakthrough of the Year Award 2025 for Ângela Gonçalves

Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging – directly challenging gender bias in medicine. The scientist from the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim is the winner of the Falling Walls Foundation’s “Breakthrough of the Year 2025” award in the Women’s Impact category.

(C) Jung/DKFZ

Each menstrual cycle, the organs of female reproductive tract organs undergo tremendous buildup and remodeling followed by breakdown and repair. For a long time, it was assumed that these events left no traces or scars in the affected organs. Ângela Gonçalves’ research has revealed the unexpected price of female reproductive capacity that results from the constant remodeling of the female reproductive tract. She has also been exploring pioneering solutions for non-invasive diagnosis by using menstrual blood. For this, the Falling Walls Foundation is honoring her with the Breakthrough of the Year award in the Women’s Impact category.

Ângela Gonçalves studied computer science at the University of Coimbra in Portugal. After a research stay at the European Space Agency, she received a scholarship for a PhD in computational molecular biology at the European Bioinformatics Institute (EMBL EBI) and received her PhD from the University of Cambridge in 2012. She then conducted postdoctoral research in population genomics at the Wellcome Trust Sanger Institute.

Since 2018, Gonçalves has headed the Division of Computational and Molecular Prevention at the German Cancer Research Center (DKFZ). Since 2022, she has also been co-head of the Digital Cancer Prevention group at the National Cancer Prevention Center, and since 2024, she has been a full professor at Heidelberg University.

In 2025, the Hector Foundation II generously increased its funding for the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim. This enabled the establishment of research areas such as prevention, early detection, and survivorship. As part of this expansion, Gonçalves was appointed to the DKFZ-Hector Cancer Institute. There, she investigates how mutated cell clones arise and spread before malignant tumors develop. To study these early stages, she combines experimental approaches with bioinformatic analyses and statistical modeling—with the long-term goal of improving cancer prevention.

The DKFZ-Hector Cancer Institute at the University Medical Center Mannheim is a collaboration between the German Cancer Research Center (DKFZ), the Mannheim Medical Faculty, Heidelberg University, and the Mannheim University Hospital.

Falling Walls Science Summit 2025

The Falling Walls Science Breakthrough of the Year awards are presented annually. They recognize the most significant scientific breakthroughs in various categories of the Falling Walls Global Call. The award winners will present their work to the public on November 9, 2025, at the Falling Walls Science Summit in Berlin.

Our latest News

discover more
Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

International evaluation names researchers whose publications have been most cited worldwide 16 researchers from Heidelberg University feature on the recently published list of “Highly Cited Researchers”. This international evaluation names researchers whose publications have been cited most frequently worldwide in their respective field or who have an outstanding track-record of publications across several disciplines. The […]

Universität Heidelberg: New DFG Research Unit in Oncology

Universität Heidelberg: New DFG Research Unit in Oncology

GenoMiCC consortium deals with functional genomics and microbiomics in colorectal cancer and is coordinated at the Medical Faculty Mannheim In the latest approval round of the German Research Foundation (DFG), Heidelberg University has been successful with a grant application for a new Research Unit in oncology. The GenoMiCC consortium pursues the goal of identifying new […]

Merck and Promega collaborate on 3D cell technology for drug discovery

Merck and Promega collaborate on 3D cell technology for drug discovery

Full text in German below. Merck und Promega arbeiten gemeinsam an 3D-Zelltechnologie für die Wirkstoffforschung Strategische Partnerschaft bündelt Know-how von Merck im Bereich Organoide mit Promegas Assay-TechnologienForschende erhalten besseren und schnelleren Zugang zu krankheitsrelevanten ZellmodellenStärkt Mercks Position bei zukunftsweisenden Tools und Lösungen auf dem Gebiet der Biologie Darmstadt, Deutschland. (06. November 2025) Merck, ein führendes Wissenschafts- […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp